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ABSTRACT 
Objectives: The problem of antimicrobial resistance (AMR) is increasing worldwide with health-related and 
economic consequences. This is a concern in Africa, including Nigeria the most populous country in 
Africa, with its high rates of infectious diseases. Approaches to reducing AMR include instigating 
antimicrobial stewardship programs (ASPs) in hospitals. Currently, no information is available regarding 
the extent of ASPs in Nigerian hospitals. Consequently, the objective was to address this starting in 
tertiary hospitals. METHODS: Cross-sectional, questionnaire-based study among tertiary healthcare 
facilities. Tertiary hospitals were chosen initially since if there are concerns in these training hospitals, 
such concerns will likely to be exacerbated in others. RESULTS: Completed questionnaires were 
received from 17 out of 25 tertiary healthcare facilities across five of the six geo-political regions of 
Nigeria. 10 (58.8%), four (23.6%), two (11.8%) and one (5.8%) respondents were in internal medicine, 
infectious diseases, medical microbiology and clinical pharmacology respectively. Only six (35.3%) 
healthcare facilities had a formal organizational structure and a team responsible for ASP. Facility-specific 
treatment recommendations, based on local AMR patterns, were available in only four (23.5%) facilities. 
Policies on approval for prescribing specified antimicrobial agents and formal procedures for reviewing 
their appropriateness after 48 hours was present in only 2 (11.8%) facilities. The cumulative antimicrobial 
susceptibility report for the previous year was available in only three (17.6%) facilities and only one facility 
routinely monitored antimicrobial use. CONCLUSION: Significant inadequacies in the availability of ASPs 







Antimicrobial resistance (AMR) is a growing public health problem with consequences including 
therapeutic failure, increasing morbidity and mortality and higher healthcare costs [1-3]. The inappropriate 
use of antimicrobials, especially in hospitals, has been shown to be responsible for the development of 
resistance to different classes of antimicrobials, especially those used for the treatment of nosocomial 
infections [4], with a pan-European study identifying a direct link between the quantity of consumed 
antibiotics and AMR [5]. The situation regarding rising AMR rates is compounded by the slow 
development of novel antimicrobial agents during the past two decades [3]. The establishment of 
antimicrobial stewardship programs (ASPs) in healthcare institutions, as well as regulation of access to 
and prescribing of antimicrobials, are some of the approaches employed towards reducing AMR [6-9]. 
The principal function of ASPs is the promotion of the rational use of antimicrobials in the hospital setting 
through formulary restrictions and pre-authorization [6, 9,10]. Additional strategies are prospective audits 
and feedback to prescribers as well as guideline development and dissemination [10-12]. Many 
developed countries have well-entrenched ASPs that have resulted in better patient outcomes and 
reduction in healthcare costs [13]. A meta-analysis of studies evaluating the effect of ASPs in inpatient 
setting in the United States showed that there was decreased antimicrobial use and improvement in 
antimicrobial resistance patterns following the instigation of ASPs [14].  A significant reduction in 
healthcare costs, especially relating to the direct cost of antimicrobials and indirect costs (reduction in 
hospital stay, and improved therapeutic outcomes), was recorded with ASPs in studies conducted in 
Saudi Arabia, Sweden and China [15-17]. Similarly, the impact of a functional ASP has been 
demonstrated in South Africa with a reduction in the quantity of antimicrobial use and costs in the hospital 
without negatively affecting patients’ outcomes [18]. However, the optimal strategies for ASPs including 
membership and activities has yet to be fully defined [9].  
 
The inappropriate use of antimicrobials is well documented in many studies conducted across Nigeria 
[19,20]. This is worrisome not only because of associated potential adverse effects and drug-drug 
interactions, but also the financial impact as only a small proportion of the population in Nigeria currently 
enjoys the coverage of health insurance schemes [21]. In view of this, the presence of any program 
promoting improved use of antimicrobials by physicians in healthcare facilities should be encouraged, 
although concerns exist about the most appropriate method [9,22].  Currently, there is little information 
regarding the availability and functionality of ASPs among Nigerian hospitals. This lack of information 
needs to be urgently addressed given the size of the population in Nigeria versus other African countries, 
and growing AMR rates in Nigeria [23-25].  
 
The principal objective of the study was to investigate the availability and mode of operation of ASPs 





2.1 Study setting 
This study was conducted among public sector tertiary healthcare facilities located in different regions of 
Nigeria. Nigeria is the most populous country in Africa with an estimated population of over 170 million. 
The country, which is divided into six geo-political zones, also operates a federal system comprising 36 
states and one Federal Capital Territory. Tertiary healthcare facilities comprise mainly Federal Medical 
Centres and University Teaching Hospitals, and they are the best-equipped in terms of personnel and 
equipment. Consequently, if there are issues regarding the nature and extent of ASPs among tertiary 
hospitals, these issues and concerns are likely to be magnified in secondary hospitals. There is some 
benefit for healthcare professionals to be part of hospital ASP programmes, either financial or as part of 
career development, although this may not be universal. 
 
The healthcare needs of the Nigerian population are catered for by both private and public healthcare 
facilities. The public healthcare system of the country currently comprises three levels of care: primary, 
secondary and tertiary. The primary level of care incorporates health centres, while the secondary level 
comprises general hospitals. As mentioned, tertiary healthcare comprises mainly Federal Medical Centres 
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and University Teaching Hospitals. Presently there are 50 university teaching hospitals owned by the 
federal or state governments in Nigeria.  
 
2.2 Study design 
A descriptive cross-sectional survey was conducted, using a self-administered mailed questionnaire, to 
ascertain the extent and nature of ongoing ASPs among tertiary hospitals. 
 
2.3 Sampling 
Purposive sampling was undertaken, using hospitals with reliable personal contacts. Five tertiary 
healthcare facilities in each of the five out of the six geo-political regions of the country were selected for 
this initial study since personnel with the highest levels of qualifications and expertise are mostly found in 
such centres. The North-eastern zone was excluded because of ongoing militant insurgency in the region 
during the study period.  
 
2.4 Data collection instrument 
The study instrument was an adaptation of the instrument developed by the Transatlantic Taskforce on 
Antimicrobial Resistance (TATFAR) Expert Panel on Stewardship Structure and Process Indicators [26]. 
The 17-item instrument consists of core indicators categorized into infrastructure, policy and practice and 
monitoring and feedback (Appendix A). 
 
2.5 Data collection process 
The questionnaires were sent via email to the focal persons of the selected institutions after initial contact 
by telephone. The focal person for each selected tertiary hospital was either a consultant medical 
microbiologist, clinical pharmacologist or a consultant physician. A time frame of two weeks was allowed 
for the return of the completed questionnaires as well as via email. Return of the completed questionnaire 
by respondents was taken as consent to participate in the study. 
 
2.6 Data analysis 
Data from the questionnaires were coded and entered into an MS Excel spreadsheet, cleaned, and 
imported into SPSS version 19 (IBM Corporation, Armonk, NY, USA) for analysis. Results were 
expressed as means, frequencies and percentages. For the non-quantitative data, content analysis using 
themes was used to summarize the responses. 
 
2.7 Ethical considerations 
The study was exempted from ethical approval according to the National Code of Health Research Ethics 
of Nigeria because it dealt with information of existing programs and services with the primary aim of 




Completed questionnaires were received from 17 out of 25 tertiary healthcare facilities across five out of 
the six geo-political regions of the country.  
 
According to the area of specialization, 10 (58.8%), four (23.6%), two (11.8%) and one (5.8%) 
respondents were specialists in internal medicine, infectious diseases, medical microbiology and clinical 
pharmacology respectively. Only four (23.5%) healthcare facilities had formal ASPs while another two 
had other committees responsible for monitoring antimicrobial use in their facilities. None of the surveyed 
healthcare facilities gave financial compensation for the time dedicated to AMS activities. In the area of 
policy and practice, four (23.5%) hospitals had treatment guidelines that were based on local 
antimicrobial susceptibility patterns while preauthorization for certain antibiotics was currently being 
practiced in only two hospitals. A review of prescribed antimicrobial agents after 48 hours was carried out 
in only three (17.6%) of the tertiary healthcare facilities. 
 
With regards to monitoring and feedback, only two centres had produced a cumulative antimicrobial 
susceptibility report in the preceding year. Similarly, regular audit of surgical antimicrobial prophylaxis was 
being undertaken in only four tertiary healthcare facilities. Monitoring of antimicrobial consumption using 
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either the Defined Daily Dose (DDD) or Days of Therapy (DOT) was currently being undertaken in only 
one healthcare facility. Full details about the availability and functionality of other components of the AMS 
programs are shown in Table 1.  
 




Statement Yes No 
Does your facility have a formal antimicrobial stewardship program accountable for 
ensuring appropriate antimicrobial use 
4(23.5) 13(76.5) 
Does your facility have a formal organizational structure responsible for 
antimicrobial stewardship (e.g. a multidisciplinary committee focused on 
appropriate antimicrobial use, pharmacy committee, patient safety committee, or 
other relevant structure)? 
6(35.3) 11(64.7) 
Is an antimicrobial stewardship team available at your facility (e.g. greater than 
one staff member supporting clinical decisions to ensure appropriate antimicrobial 
use)? 
6(35.3) 11(64.7) 
Is there a physician identified as a leader for antimicrobial stewardship activities at 
your facility? 
5(29.4) 12(70.6) 
Is there a pharmacist responsible for ensuring appropriate antimicrobial use at 
your facility? 
3(17.6) 14(82.4) 
Does your facility provide any salary support for dedicated time for antimicrobial 
stewardship activities (e.g. percentage of full-time equivalent [FTE] staff for 
ensuring appropriate antimicrobial use)? 
0(0) 17(100) 
Does your facility have the information technology (IT) capability to support the 
needs of the antimicrobial stewardship activities? 
4(23.5) 13(76.5) 
 
Policy and Practice 
 
Statement Yes No 
Does your facility have facility-specific treatment recommendations based on local 
antimicrobial susceptibility to assist with antimicrobial selection for common 
clinical conditions? 
4(23.5) 13(76.5) 
Does your facility have a written policy that requires prescribers to document an 
indication in the medical record or during order entry for all antimicrobial 
prescriptions? 
7(41.2) 10(58.8) 
Is it routine practice for specified antimicrobial agents to be approved by a 
physician or pharmacist in your facility (e.g. preauthorization)? 
2(11.8) 15(88.2) 
Is there a formal procedure for a physician, pharmacist, or other staff member to 
review the appropriateness of an antimicrobial at or after 48 hours from the initial 
order (post-prescription review)? 
3(17.6) 14(82.4) 
 
Monitoring and Feedback 
 
Statements Yes No 
Has your facility produced a cumulative antimicrobial susceptibility report in the 
past year? 
2(11.8) 15(88.2) 
Does your facility monitor if the indication is captured in the medical record for all 
antimicrobial prescriptions? 
4(23.5) 13(76.5) 
Does your facility audit or review surgical antimicrobial prophylaxis choice and 
duration? 
4(23.5) 13(76.5) 





Does your facility monitor antimicrobial use by grams (Defined Daily Dose [DDD]) 
or counts (Days of Therapy [DOT]) of antimicrobial(s) by patients per days? 
1(5.9) 16(94.1) 
Has an annual report focused on antimicrobial stewardship (summary 
antimicrobial use and/or practices improvement initiatives) been produced for your 






Instigation of ASPs is one of the major interventions against AMR worldwide. However in our study, only 
four (23.5%) of the surveyed tertiary facilities in Nigeria had ASPs in existence. This will have a significant 
impact on the rational use of antimicrobials and attendant patient outcomes in Nigeria unless addressed, 
especially if our findings are replicated or even worse in secondary care facilities that currently lack the 
infrastructure of tertiary facilities. Having said this, these concerns are also seen in more developed 
countries where there are also variable levels of ASPs [9, 16,27,28]. A study conducted in 2013 among 
38 children hospitals in the USA, concluded that only 16 of them had existing ASPs, while 15 were in the 
process of establishing them [28]. Another study characterizing the structure and functioning of ASPs in 
Veterans healthcare facilities across the USA in 2012 also found ASP teams present in only 38% of the 
surveyed hospitals [29]. The relatively low number of healthcare facilities having functional ASPs was 
also highlighted in a 2014 study conducted in Queensland, Australia, with only 19% of facilities having 
ASPs [30].  In contrast, 92.6% of hospitals surveyed in a Korean study had functional ASPs [27].   
 
Research has shown the positive impact of having infectious diseases physician, clinical microbiologist, 
clinical pharmacologists and clinical pharmacists trained in infectious diseases in addition to management 
staff as members of the ASP team [6]. In this study, a physician was identified as the team leader of the 
ASPs in five (83.3%) of the healthcare facilities where ASPs had been instigated while three tertiary 
facilities (50%) had a pharmacist responsible for appropriate antimicrobial use.  Due to manpower 
constraints, especially in clinical sub-specialties such as infectious diseases, clinical microbiology and 
clinical pharmacology in Nigeria, it is impossible currently to meet these membership criteria in existing 
ASPs. However, physicians from other sub-specialties, nurses and other healthcare professionals such 
as pharmacists can be incorporated after pre-requisite training to facilitate the functioning of ASPs in their 
facilities. This is already happening in other countries [8], and has already led to the development of 
guidelines and positioning statements among pharmacists and other professionals in South Africa [10,31].   
 
None of the centres that participated in this study had any special salary or funding support for the 
members of their ASP teams. This is not peculiar to Nigeria as lack of adequate funding for ASP teams 
has been identified in studies conducted in different parts of the world [30]. 
 
4.2 Policy and Practice 
At the level of policy and practice, only four (23.5%) tertiary hospitals had facility-specific treatment 
recommendations based on local antimicrobial susceptibility. This suggests that treatment with 
antimicrobials in the majority of these hospitals was being undertaken empirically with potential 
consequences such as therapeutic failure, higher costs of healthcare, and increasing levels of AMR.  
 
Pre-authorization is typically the most common form of intervention used in ASPs; however, only 8% of 
tertiary hospitals in this study had pre-authorization programmes in place.  In practice, this means that all 
cadres of physicians (from interns to consultants) can prescribe any type of antimicrobial even the so-
called “reserved” antimicrobials. This is in contrast to 92.6% and 88% of hospitals in South Korea and 
Australia respectively having pre-authorization as a core interventional strategy [27,30].  The pre-
authorization of ciprofloxacin prescriptions, in a study conducted in the USA, was associated with a 
positive effect on the susceptibility of E. coli isolates to ciprofloxacin [32].  The importance of pre-
authorization in reducing the use of broad-spectrum antibiotics, and its associated higher healthcare 
costs, have also been reported in other studies [33,34]. Another way of limiting the inappropriate use of 
antimicrobials in the hospital setting is post-prescription reviews after 48 hours when the results of the 
microbial culture and sensitivity would have been reported.  In this study, only three (17.6%) hospitals had 
post-prescription reviews in place. While this may indicate a lack of consideration towards bacterial 
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culture and sensitivity in some cases, most physicians would typically review the prescribed antimicrobials 
based on culture and sensitivity results without a formal post-prescription review.  The clinical advantages 
of a post-prescription review, which has been shown in several studies, include a reduction in patients’ 
exposure to antibiotics, shortening the duration of hospital stay, and a reduction in the rate of relapse of 
infections [35].  
 
4.3 Monitoring and Feedback 
Local knowledge of antimicrobial susceptibility is essential especially when choosing antibiotics for the 
empiric treatment of infections. Only two (11.8%) hospitals in this study had produced a cumulative 
antimicrobial susceptibility report in the preceding year. Although there are several small and isolated 
cross-sectional antimicrobial susceptibility, and/or resistance studies, conducted in Nigerian hospitals 
[36,37], a need exists for more comprehensive annual facility sponsored studies to be conducted using 
either the Clinical Laboratory Standards Institute (CLSI) or the European Committee on Antimicrobial 
Susceptibility Testing (EUCAST) guidelines [38]. This should be a priority for the future building on 
examples in other African countries [39], with ongoing plans also in place among a number of African 
countries as part of National Antimicrobial Plans to improve sensitivity testing and their use, with the 
findings guiding future empiric use [39].   
 
The documentation of the indication for antibiotic use is also important as part of ASPs to improve the 
quality of prescribing. The indications for antimicrobial use were captured in patients’ case notes in only 
four (23.5%) of the participating hospitals. The use of surgical antimicrobial prophylaxis was also only 
monitored in four participating hospitals in this study. This practice was typically suboptimal, which is a 
concern as non-compliance with guidelines regarding the use of antimicrobial surgical prophylaxis would 
likely contribute to the development of AMR. We also see concerns with the use of surgical antimicrobial 
prophylaxis in other African countries [40,41]. Finally, only one hospital monitored antimicrobial use in its 
facility using either of the standard indices and tools for quantification of drug use, namely Defined Daily 
Dose (DDD) or Days of Therapy (DOT). This however might be a consequence of inadequate knowledge 
of drug utilization research methodology in Nigeria, which is starting to be addressed with the formation of 
Pan-African groups such as the MURIA group (Medicines Utilisation Research in Africa) with the help of 
the World Health Organisation and others [42,43]. The lack of usage of standard tools and methodologies 
limits the ability of physicians and other healthcare providers to monitor the quantity and quality of 
antibiotic use over time in their facilities. It also does not allow for the correlation of antibiotic consumption 
and resistance patterns within their facilities to improve future antibiotic prescribing. 
 
LIMITATIONS 
The study was conducted only in public tertiary level healthcare facilities across several regions of the 
country and as such our findings may not reflect the reality in among private and faith-based healthcare 
facilities in Nigeria However, there was a good geographical spread. In addition, if concerns regarding 
ASPs were found in public tertiary hospitals in Nigeria, these are likely to be magnified in secondary care 
hospitals with their lack of trained specialists and other structures. The purposive nature of the sampling 
approach used may also be associated with an element of bias.  We also explored descriptively the 
availability and structure of ASPs but did not investigate in depth how ASPs function in practice. This will 
be followed up through mixed-method research in the future. The impact of the ASP services on 
antimicrobial utilization and resistance was also not explored, and this will be another area for future 
research. However, we believe our findings are robust necessitating an urgent need for the Nigerian 
Government to instigate ASPs staring in tertiary hospitals and progressing wider to reduce current AMR 
rates. 
 
5. CONCLUSIONS  
ASPs are lacking in a substantive proportion of tertiary Nigerian hospitals, and they furthermore function 
sub-optimally where available. Given the highlighted problems of inappropriate antimicrobial use in 
Nigeria and its associated consequences, there is an urgent need for concerted efforts to make ASPs 
functional in Nigeria, starting initially with the tertiary healthcare facilities. This could begin with 
educational programs in healthcare facilities organized by the Ministry of Health highlighting the 
importance of appropriate antibiotic use, and followed up with structures to monitor the establishment of 
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ASPs and their influence on future antibiotic use. The program could thereafter be cascaded to secondary 
and primary care levels for optimal results across the country.   
 
Highlights 
 AMR is a growing concern especially in sub-Sahara Africa with its high rate of infectious diseases. 
 Reducing AMR rates can be aided through initiatives such as antimicrobial stewardship programmes 
(ASPs). However, little is currently known about ASPs among leading hospitals (tertiary hospitals) in 
Nigeria 
 The qualitative research showed limited implementation of ASPs among tertiary hospitals in Nigeria, 
with only just over one third of tertiary hospitals having a formalized structure and team responsible 
for ASPs 
 Under a quarter of tertiary hospitals have specific treatment recommendations in place based on local 
antimicrobial resistance patterns, and only 12% of tertiary hospitals had a formal procedure in place 
for reviewing the appropriateness of antibiotic prescribing after 48 hours 
 Susceptibility reports of antimicrobial resistance patterns the previous year were only available in 
18% of facilities and only one out of 25 surveyed hospitals currently routinely monitor antimicrobial 
utilization 
 The Ministry of Health and other key stakeholders need to get together to urgently address the lack of 
ASPs and other initiatives in hospitals to improve antimicrobial use in Nigeria else AMR rates will 
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ANTIBIOTIC STEWARDSHIP PROGRAM SURVEY QUESTIONNAIRE 
Kindly complete this questionnaire by typing YES/NO in front of each question. The aim of this 
study is to assess antibiotic stewardship program in selected Nigerian healthcare facilities. We 
will appreciate your timely completion and return of the questionnaire. 
The completed questionnaire can be sent to: jofadare@gmail.com 
Thank you. 
 
Name of Respondent (Optional):  
Work Title (Consultant Physician, Consultant Medical Microbiologist, Other ):  
If other, please state: 
Name of Healthcare Facility/Organization:  
Location (City):  
Category of Healthcare Facility (Secondary/Tertiary):   
 
Infrastructure 
1. Does your facility have a formal antimicrobial stewardship program accountable for ensuring 
appropriate antimicrobial use?  Yes/ No 
2. Does your facility have a formal organizational structure responsible for antimicrobial 
stewardship (e.g., a multidisciplinary committee focused on appropriate antimicrobial use, 
pharmacy committee, patient safety committee, or other relevant structure)?  Yes/ No 
3. Is an antimicrobial stewardship team available at your facility (e.g., greater than one staff 
member supporting clinical decisions to ensure appropriate antimicrobial use)? Yes/ No 




5. Is there a pharmacist responsible for ensuring appropriate antimicrobial use at your facility?  
Yes/ No 
6. Does your facility provide any salary support for dedicated time for antimicrobial stewardship 
activities (e.g., percentage of full-time equivalent [FTE] staff for ensuring appropriate 
antimicrobial use)? Yes/ No 
7. Does your facility have the information technology (IT) capability to support the needs of the 
antimicrobial stewardship activities? Yes/ No 
Policy and practice 
8. Does your facility have facility-specific treatment recommendations based on local 
antimicrobial susceptibility to assist with antimicrobial selection for common clinical conditions?  
Yes/ No 
9. Does your facility have a written policy that requires prescribers to document an indication in 
the medical record or during order entry for all antimicrobial prescriptions?  Yes/ No 
10. Is it routine practice for specified antimicrobial agents to be approved by a physician or 
pharmacist in your facility (eg, preauthorization)? Yes/ No 
11. Is there a formal procedure for a physician, pharmacist, or other staff member to review the 
appropriateness of an antimicrobial at or after 48 hours from the initial order (post-prescription 
review)?  Yes/ No 
Monitoring and feedback 
12. Has your facility produced a cumulative antimicrobial susceptibility report in the past year? 
Yes/ No 
13. Does your facility monitor if the indication is captured in the medical record for all 
antimicrobial prescriptions? Yes/ No 
14. Does your facility audit or review surgical antimicrobial prophylaxis choice and duration? Yes/ 
No 
15. Are results of antimicrobial audits or reviews communicated directly with prescribers? Yes/ 
No 
16. Does your facility monitor antimicrobial use by grams (Defined Daily Dose [DDD]) or counts 
(Days of Therapy [DOT]) of antimicrobial(s) by patients per days? Yes/ No 
17. Has an annual report focused on antimicrobial stewardship (summary antimicrobial use and/or 
practices improvement initiatives) been produced for your facility in the past year?  Yes/ No 
